Inception Return
(4/11/2017)
|
5.31 %
|
|
YTD Return
|
23.32 %
|
|
NAVPS
(4/22/2024)
|
$12.34
|
|
Change
|
($0.24) / -1.94 %
|
|
|
Growth of $10,000
(As of March 31, 2024)
|
|
MER
|
3.02 %
|
|
Assets ($mil)
|
-
|
|
Rank (1Yr)
|
78/177
|
|
Std Dev (3Yr)
|
24.12 %
|
|
Volatility Ranking (3Yr)
|
10/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Front Fee Only
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The Fund’s objective is to achieve growth by investing primarily in equity securities of companies engaged in nutrition, nutraceuticals and new forms of medicines and pharmaceutical solutions.
|
Fund Manager
Ninepoint Partners LP
Portfolio Manager
Ninepoint Partners LP
Sub-Advisor
Douglas Waterson, Faircourt Asset Management Inc.
Charles Taerk, Faircourt Asset Management Inc.
|
|
Asset Allocation
(As of March 31, 2024)
|
Sector Allocation
(As of March 31, 2024)
|
Geographic Allocation
(As of March 31, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Green Thumb Industries Inc | US Equity | Healthcare | United States | 17.71% |
| Trulieve Cannabis Corp | US Equity | Healthcare | United States | 11.03% |
| Verano Holdings Corp Cl A | US Equity | Consumer Services | United States | 9.81% |
| Costco Wholesale Corp | US Equity | Consumer Services | United States | 6.32% |
| Terrascend Corp | Canadian Equity | Healthcare | Canada | 5.30% |
| Merck & Co Inc | US Equity | Healthcare | United States | 4.63% |
| Eli Lilly and Co | US Equity | Healthcare | United States | 4.61% |
| Johnson & Johnson | US Equity | Healthcare | United States | 4.32% |
| Abbott Laboratories | US Equity | Healthcare | United States | 4.17% |
| UnitedHealth Group Inc | US Equity | Healthcare | United States | 3.33% |
Performance Data
(As of March 31, 2024)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
7.93
|
23.32
|
20.83
|
23.32
|
27.21
|
-16.64
|
-7.89
|
-
|
|
Benchmark
|
4.14
|
6.62
|
15.26
|
6.62
|
13.96
|
9.11
|
9.96
|
7.67
|
|
Quartile Ranking
|
1
|
1
|
2
|
1
|
2
|
4
|
4
|
-
|
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
Fund
|
-6.09
|
-37.61
|
-6.06
|
37.72
|
-6.72
|
16.79
|
-
|
-
|
-
|
-
|
|
Benchmark
|
11.75
|
-5.84
|
25.09
|
5.60
|
22.88
|
-8.89
|
9.10
|
21.08
|
-8.32
|
10.55
|
|
Quartile Ranking
|
4
|
4
|
4
|
2
|
4
|
1
|
-
|
-
|
-
|
-
|